Drugs Classes Manufacturers Shortages Markets News

Pillstats aggregates public data: openFDA NDC Directory · CMS NADAC. US coverage today; UK · CA · AU expanding. Benchmark prices measure specific points in the supply chain - a benchmark, not a quote. Labeler names are as reported to FDA; name variants are merged into canonical entities (see methodology). Not medical advice. Join the waitlist for watchlists and supply alerts.

Grisofulvin - manufacturers, supply & price · Pillstats

Drugs / Grisofulvin

Rx only · Suspension · Oral

Grisofulvin

Griseofulvin

1 ACTIVE SUPPLIER - US

openFDA · updated weekly

US1 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCD01AA08

RxCUI (US)5021

US makers1 labelers

Packages1

DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.

$0.252

Latest avg · Aug 19, 2026

-6%

Since Dec 17, 2025

Active US suppliers

100%

Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.

2.8K

Rx · 2026 Q1

1.1M

Units dispensed

-19%

Rx vs. year ago

Quarters · since 2024 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Cipla USA Inc.	generic	1	SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.

At a glance

FormSuspension
RouteOral
TypeRX
US NDCs1
Packages1
Labelers1

Watch this drug

Shortages, supplier exits, and recalls - in your account feed.

Monograph & sources

US prescribing informationDAILYMED
Price methodologySOON